Search
March 11, 2022

CDC-Abt Study Shows Pfizer Vaccine Is Moderately Effective for Children

Body

More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.

Read More

COVID-19 in North America

APPAM Fall Research Conference 2026

Abt is a Gold Sponsor of APPAM 2026. Catch us in Boston, in our sessions and at booth 304, or connect with the team here!

Learn More
Event

Making Data Meaningful: The Power of Data Storytelling in CMS Rural Health Transformation Programs

Discover how data storytelling can help states communicate the impact of CMS Rural Health Transformation Programs, demonstrate results, and sustain investments.

Learn More
Blog

National Association of Medicaid Directors (NAMD) Fall Conference 2026

Abt Global is a Sapphire sponsor of the NAMD 2026 Fall Conference. Find our Medicaid policy and data team at Booth 122.

Learn More
Event

Tracking State and Federal Investments and Policies to Address Homelessness in Los Angeles County – An Examination for Measure A Goals

For the Conrad N. Hilton Foundation, Abt assessed how federal and state policy shifts may affect LA County’s progress toward its Measure A goals.

Learn More
Publication